× |
|
DEXTROSE MONOHYDRATE Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
DOCUSATE SODIUM Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
× |
|
ENTRESTO (sacubitril; valsartan) Drug Profile, 2024 |
$699.00 |
|
$699.00 |
× |
|
SHELLAC Drug Excipient Business Development Opportunity Report, 2024 |
$699.00 |
|
$699.00 |
|